Exclusion of CD45 from the T-cell receptor signaling area in antigen-stimulated T lymphocytes  by Leupin, Olivier et al.
Brief Communication 277
Exclusion of CD45 from the T-cell receptor signaling area in
antigen-stimulated T lymphocytes
Olivier Leupin*, Rossana Zaru*, Thierry Laroche†, Sabina Müller* 
and Salvatore Valitutti*
T lymphocytes are activated by the engagement of their
antigen receptors (TCRs) with complexes of peptide and
major histocompatibility complex (MHC) molecules
displayed on the cell surface of antigen-presenting cells
(APCs) [1]. An unresolved question of antigen
recognition by T cells is how TCR triggering actually
occurs at the cell–cell contact area. We visualized
T-cell–APC contact sites using confocal microscopy and
three-dimensional reconstruction of z-sections. We
show the rapid formation of a specialized signaling
domain at the T-cell–APC contact site that is
characterized by a broad and sustained area of tyrosine
phosphorylation. The T-lymphocyte cell-surface
molecule CD2 is rapidly recruited into this signaling
domain, whereas TCRs progressively percolate from the
entire T-cell surface into the phosphorylation area.
Remarkably, the highly expressed phosphatase CD45 is
excluded from the signaling domain. Our results indicate
that physiological TCR triggering at the T-cell–APC
contact site is the result of a localized alteration in the
balance between cellular kinases and phosphatases.
We therefore provide experimental evidence to support
current models of T-cell activation based on CD45
exclusion from the TCR signaling area [2–4]. 
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Results and discussion 
Two recent reports by Monks et al. [5] and Grakoui et al. [6]
have provided evidence for the existence of specialized
signaling domains at the contact areas between T cells and
APCs. These studies have pioneered new techniques to
examine different aspects of T-cell activation by visualiz-
ing the array of surface molecules and signaling compo-
nents recruited into the contact area. We have recently
shown that a marked and sustained area of tyrosine phos-
phorylation is rapidly formed at the contact interface
between T cells and APCs [7] during sustained interaction
between the two. Here, we have used this area of phos-
phorylation as a marker of localized signal transduction to
identify molecules that could be selectively included in, or
excluded from, the signaling process. 
Figure 1
Slow recruitment of TCR–CD3-ζ complexes into the TCR signaling
domain. T cells (clone 6396p5.1.2) were conjugated with B cells
transformed with Epstein–Barr virus (EBV; red). After different culture
times, cells were stained with an anti-phosphotyrosine monoclonal
antibody (blue) and an anti-ζ chain monoclonal antibody (green).
(a) Three-colour image of a T cell interacting with an unpulsed APC.
(b–d) Conjugate formed between a T cell and a peptide-pulsed APC
after 5 min at 37°C; in (c,d) either the blue or green colour has been
removed. (e–g) Conjugate formed between a T cell and a peptide-
pulsed APC after 30 min at 37°C; in (f,g) either the blue or the green
colour has been removed. Magnification 63×, 1.4 oil. Data are from one
representative experiment out of three. Similar results were obtained
with two different T cell clones (KS140 and SDM3.5).
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We first focused on the surface distribution of the multi-
meric TCR receptor complexes (TCR/CD3-ζ), which are
composed of the clonotypic αβ dimer, the CD3 γδε chains
and the ζ homodimer. As shown in Figure 1, at early time
points after conjugate formation (5 minutes, Figure 1a–d)
only a relatively small fraction of TCRs were recruited
into the phosphorylation area. In addition, in a significant
fraction of conjugates, no enrichment of ζ-chains was
detected in the broad area of tyrosine phosphorylation at
the 5 minute time point (data not shown). At later time
points (30 minutes, Figure 1e–g), however, TCRs tended
to accumulate in the center of the contact area from where
they would eventually be internalized and targeted to the
lysosomes for degradation [8].
These results show that antigen-driven activation of
protein tyrosine kinases does not require an immediate
massive polarization of TCR–CD3-ζ complexes towards
the APCs, therefore supporting the notion that TCRs are
progressively recruited into the areas of contact between
T cells and APCs, where they are serially triggered [9–11]. 
In parallel experiments, we tested the role of CD2 in the
formation of the signaling area where phosphotyrosine
staining was detected. As shown in Figure 2, CD2 was
rapidly recruited into the area of cell–cell adhesion in
T cells stimulated for 5 minutes with peptide-pulsed APCs.
This observation indicates that the avidity of interaction
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Figure 2
CD2 rapidly accumulates in T-cell–APC contact sites. T cells (clone
6396p5.1.2) were conjugated with EBV-transformed B cells (red).
After 5 min at 37°C, cells were stained with an anti-phosphotyrosine
monoclonal antibody (blue) and an anti-CD2 monoclonal antibody
(green). (a) Three-colour image of a T cell interacting with an unpulsed
APC. (b–d) Conjugate formed between T cells and a peptide-pulsed
APC; in (c,d) either the blue or the green colour has been removed.
Magnification 63×, 1.4 oil. Data are from one representative experiment
out of four. Similar results were obtained with two different T cell
clones (KS140 and SDM3.5).
Figure 3
CD45 is excluded from the TCR signaling area.
T cells (clone 6396p5.1.2) were conjugated
with peptide-pulsed EBV-transformed B cells
(red). After 5 min at 37°C, cells were stained
with an anti-phosphotyrosine monoclonal
antibody (blue) and either the (a–d) 10G10
anti-CD45 monoclonal antibody or the (e–h)
9.4 anti-CD45 monoclonal antibody (green).
(a–d) Two different projections of the same
conjugate: (a,b) are longitudinal sections; (c,d)
show the T-cell–APC contact area observed
from inside the T cell. In (b,d) the blue staining
has been removed to highlight the exclusion of
CD45 from the phosphorylation area. (e–h)
Two different projections of the same
conjugate: (e,f) are longitudinal sections; (g,h)
show the T-cell–APC contact area observed
from inside the T cell. In (f,h) the blue staining
has been removed to highlight the exclusion of
CD45 from the phosphorylation area.
Magnification 63×, 1.4 oil. Data are from one
representative experiment out of five. Similar
results were obtained with two different T-cell
clones (KS140 and SDM3.5).
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between human CD2 and its ligand CD58 is rapidly
enhanced in T-cell–APC conjugates by TCR triggering,
and that CD2 might play a role in amplifying TCR-coupled
signal transduction in antigen-stimulated T cells. This is in
agreement with a recent report showing that CD2 lowers
the threshold of T-cell activation under conditions in which
only a small fraction of TCRs is engaged [12]. In addition,
our observations support the notion that interaction
between CD2 and CD58 plays a major role in tightening
adhesion in T-cell–APC conjugates, therefore favouring the
TCR–peptide–MHC interaction [13].
We finally investigated whether CD45 co-localized with
the signaling area. For this study, we took advantage of the
observation that the EBV-transformed B cell lines we cur-
rently use as APCs express a very low level of CD45 as
compared with T cells (data not shown). We used an exten-
sive panel of anti-CD45 antibodies to exclude the possibil-
ity that the observed phenotype could result from staining
artefacts such as conformational changes or steric hindrance
within molecular clusters (see Supplementary material).
When monoclonal antibodies directed against the common
CD45 extracellular domain were used (10G10 and 9.4), a
significant reduction in the CD45 staining was observed at
the T-cell–APC signaling area, as shown in a typical confo-
cal optical section (Figure 3a,b,e,f). Accordingly, staining
with the monoclonal antibody UCHL1, which is directed
against the most external portion of CD45 (Figure 4a,c),
and intracellular staining with anti-lymphocyte phos-
phatase-associated phosphoprotein (LPAP), a protein that
interacts with CD45 (see Supplementary material) [14],
gave similar results. For each antibody, 120 T-cell–APC
conjugates exhibiting tyrosine phosphorylation were ran-
domly selected from at least three independent experi-
ments and scored for CD45 exclusion in a double-blind
study. CD45 was clearly excluded from the signaling area
in 80–90% of the conjugates. In the remaining conjugates,
CD45 exclusion was still detectable but less pronounced.
Similar results were obtained with two additional anti-
CD45 antibodies (4B2 and 422, data not shown). T cells
interacting with APCs that were not pulsed with specific
peptide exhibited no CD45 exclusion (see Supplementary
material). To better define the spatial relationship between
CD45 and the signaling domain, we performed three-
dimensional reconstruction of the z-sections recorded for
each T-cell–APC conjugate. As shown in Figure 3c,d,g,h
and in Figure 4b,d, this analysis also revealed a clear exclu-
sion of CD45 from the TCR signaling area. To measure the
actual fluorescence of unprocessed images, a region was
drawn at the cell–cell contact site of the T-cell–APC conju-
gates. The median green fluorescence intensity of the
selected areas compared with the remaining T-cell surface
is shown in the Supplementary material. 
Our results provide the first experimental evidence of
CD45 exclusion from the TCR signaling area in antigen-
stimulated T lymphocytes, a mechanism that has been
proposed to be a critical step in the TCR triggering
cascade in several models of T-cell activation [2–4].
Our results are in apparent contrast to recently published
data showing no CD45 exclusion from the contact site in
mouse T-cell–APC conjugates [15]. This discrepancy might
be explained by the fact that different cells and different
staining conditions were used in the two studies. In addi-
tion, our results might be due to the higher physiological
affinity of the CD2–CD58 interaction in human cells com-
pared with the CD2–CD48 interaction in mouse cells [16],
which may result in an improved exclusion of CD45. 
In conclusion, it is tempting to speculate that the follow-
ing sequence of events takes place during the process of
antigen recognition by T lymphocytes. In resting condi-
tions, cellular phosphatases exert a dominant effect on cel-
lular kinases [4,17]. T cells form random conjugates with
other cell types, which are mediated by the interaction
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Figure 4
CD45 exclusion is detected with anti-
CD45-RO antibodies (RO is the CD45
isoform expressed on activated T cells).
T cells were conjugated with peptide-pulsed
EBV-transformed B cells (red). After 5 min at
37°C, cells were stained with an anti-
phosphotyrosine monoclonal antibody (blue)
and the monoclonal antibody UCHL1 (green).
(a–d) Two different projections of the same
conjugate: (a,c) are longitudinal sections;
(b,d) show the T-cell–APC contact area
observed from inside the T cell. In (c,d) the
blue staining has been removed to highlight
the exclusion of CD45 from the
phosphorylation area. Magnification 63×,
1.4 oil. Data are from one representative
experiment out of three.
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between relatively long adhesion molecules such as
LFA-1 and ICAM1 [2,3]. Upon conjugation with the
cognate APC, some labile tight adhesion microdomains
are formed through the interaction of a few CD2 and
CD58 molecules. In these very small and unstable areas, a
few TCRs are triggered by peptide–MHC complexes.
This in turn leads to localized activation of signal trans-
duction, resulting in strengthening of cell–cell adhesion
and recruitment of CD2 into the contact site [2,3]. The
accumulated CD2 binds CD58 on the APC surface bring-
ing the T-cell and APC membranes closer, to a distance
small enough to facilitate interactions between TCRs and
their ligands. Because CD45 is a large, highly glycosylated
molecule, it does not have access to this narrow area of inti-
mate contact where the balance between kinases and phos-
phatases shifts in favour of kinases [4]. As a consequence,
the signaling process that is initially weak and localized,
expands in a ‘catalytic’ fashion and occupies a larger
portion of the T-cell–APC contact site. TCRs slowly per-
colate through this area of ‘dominant kinases’ and are
trapped by engagement with peptide–MHC complexes for
long enough to be phosphorylated and to trigger the signal-
ing cascade [18]. Productively engaged TCRs are removed
from the T-cell surface by internalization while new ones
take their place, resulting in an amplified and sustained
signal [9]. The progressive depletion of TCRs and signal-
ing components by their degradation [8,19] allows re-estab-
lishment of the dominant role of cellular phosphatases,
leading to the extinction of signal transduction. 
Supplementary material
Figures showing the exclusion of LPAP from the TCR signaling area
and surface staining of CD45 in non-stimulated T cells, a table showing
measurements of CD45 staining at the T-cell–APC contact sites and
additional methodological details are available at http://current-
biology.com/supmat/supmatin.htm.
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